Effectiveness and Safety of the Electrically Powered Orthopedic Exercise Device on Gait Ability in Patients With Hip Joint Diseases

NCT ID: NCT07147530

Last Updated: 2025-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-07

Study Completion Date

2026-04-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Gait is an essential daily activity performed through the complex coordination of the central and peripheral nervous systems and the musculoskeletal system. Gait disorders can negatively affect quality of life, increase the risk of falls, decrease the ability to perform daily activities, and limit physical activity. Various musculoskeletal diseases can cause gait impairment, with hip osteoarthritis and osteonecrosis of the femoral head (ONFH) being the most representative conditions.

Various interventions can be attempted during the early stages of hip joint disease progression. However, improvement in symptoms does not necessarily indicate a halt in disease progression. As the condition advances in most patients, thinning of the full-thickness hip cartilage or collapse of the femoral head occurs, leading to restricted hip range of motion, weakness of the lower limb muscles and functional deterioration, resulting in the need for total hip arthroplasty.

THA offers significant improvements in pain relief and function, regardless of the patient's preoperative status, and can reduce long-term healthcare costs. However, performing THA at an early stage with minimal functional improvement is not recommended. Postoperative complications, such as infections, aseptic loosening, and instability, are potential risks, with younger patients aged 45-64 showing higher revision surgery rates compared to those aged 65 and older. This highlights the need for new interventions that can delay the time to surgery while improving gait function and muscle strength.

Therefore, this study aims to explore the clinical feasibility of the Angel Suit H10 (Angelrobotics, Seoul, Korea) by assessing whether wearing the Electrically Powered Orthopedic Exercise Device improves gait function in patients with hip joint diseases, along with evaluating user satisfaction and device safety.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

(1) Overview of study design This investigator-initiated exploratory study is a pilot study designed to evaluate the effectiveness and safety of the Electrically Powered Orthopedic Exercise Device by measuring and analyzing gait function and balance ability in patients with hip joint diseases under both non-wearing and wearing conditions.

(2) Experimental Group and Evaluation Procedures

1. Participant Selection:

This study includes a single test group with a total of 30 participants. The selection of participants for the electrically powered orthopedic exercise device and the overall study process will be conducted under the prescription and guidance of a rehabilitation medicine specialist, and supervised by assistants (physicians and occupational therapists). The examiner will collect clinical information and conduct a screening assessment for each participant.
2. Evaluation Phase Without Device:

After the screening test, participants undergo assessments of walking ability and balance without wearing the motorized orthopedic exercise device. A 10-minute rest period is provided between each assessment. If the participant wishes, additional rest time is allowed and recorded in the case report form. The assessments include the 10-Meter Walk Test, the 6-Minute Walk Test, the Timed Up and Go Test, and the Berg Balance Scale. These evaluations are conducted in the rehabilitation function testing room on the second floor of the facility under the supervision of the research team (physician and either a physical or occupational therapist).
3. Pre-Adaptation Phase:

After the evaluations without the device, a total of four adaptation sessions are conducted, during which the participant wears the device and performs short-distance walking within 10 meters. These sessions are designed to help the participant become familiar with the operation and wearing method of the H10 device. Appropriate device settings are configured for each participant to minimize any potential inexperience or anxiety during use. Participants must complete all four adaptation sessions, and each session should be conducted within a two-week interval.
4. Evaluation Phase:

After completing all four adaptation sessions, participants undergo assessments of walking ability and balance while wearing the motorized orthopedic exercise device. A 10-minute rest period is provided between each assessment. If the participant wishes, additional rest time is allowed and recorded in the case report form. The assessments include the 10-Meter Walk Test, the 6-Minute Walk Test, the Timed Up and Go Test, and the Berg Balance Scale. These evaluations are conducted in the rehabilitation function testing room on the second floor of the facility under the supervision of the research team (physician and either a physical or occupational therapist). After the evaluations are completed, a usability and satisfaction survey regarding the motorized orthopedic exercise device is conducted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Researchers will compare non-wearing and wearing conditions of the electrically powered orthopedic exercise device walking speeds, spatiotemporal parameters, balance in participants and does not establish a control group.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Wearing conditions of Electrically Powered Orthopedic Exercise Device

Participants will undergo gait and balance function tests under both non-wearing and wearing conditions of the electrically powered orthopedic exercise device

Group Type EXPERIMENTAL

Electrically Powered Orthopedic Exercise Device

Intervention Type DEVICE

Participants who pass the screening undergo an evaluation of gait function and balance ability without wearing the Electrically Powered Orthopedic Exercise Device. Afterward, the patient wears the motorized orthopedic exercise device for a total of four adaptation sessions. In each session, the patient performs short-distance walking within 10 meters while wearing the device to explore the appropriate assistive mode and level of support that match their physical condition. No evaluations are conducted while wearing the device during sessions 1, 2, and 3. After the 4th session, an evaluation identical to the one conducted without the device is performed while wearing it, and a satisfaction survey is conducted.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrically Powered Orthopedic Exercise Device

Participants who pass the screening undergo an evaluation of gait function and balance ability without wearing the Electrically Powered Orthopedic Exercise Device. Afterward, the patient wears the motorized orthopedic exercise device for a total of four adaptation sessions. In each session, the patient performs short-distance walking within 10 meters while wearing the device to explore the appropriate assistive mode and level of support that match their physical condition. No evaluations are conducted while wearing the device during sessions 1, 2, and 3. After the 4th session, an evaluation identical to the one conducted without the device is performed while wearing it, and a satisfaction survey is conducted.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Individuals aged 19 or older
2. Individuals diagnosed with hip osteoarthritis of Kellgren-Lawrence (K-L) Grade 1-4
3. Individuals diagnosed with avascular necrosis of the femoral head at Association Research Circulation Osseous(ARCO) Stage 1-4
4. Individuals able to sit at the edge of a bed without assistance and stand for 10 seconds regardless of support
5. Individuals who are Functional Ambulatory Category (FAC) score of 1-3
6. Individuals who visited Yongin Severance Hospital, understood the study, and signed informed consent
7. Individuals who have adequate cognitive ability (Korean Mini-Mental State Examination score ≥ 20)

Exclusion Criteria

1. Individuals who have contraindications for lower limb weight-bearing such as severe joint contractures, osteoporosis, or untreated fractures
2. Individuals who have progressive or unstable brain diseases or neurological paralysis from stroke
3. Individuals who have active infections or open wounds hindering device use
4. Individuals who have significant leg length discrepancies
5. Individuals who have severe deformities or contractures in the lower extremities
6. Individuals who have history of poliomyelitis
7. Individuals inable to maintain seated or standing positions independently
8. Individuals who have severe spasticity (Modified Ashworth Scale grade ≥ 2)
9. Individuals who have bone metastases from cancer
10. Individuals who have severe internal diseases affecting device use (e.g., cardiovascular or respiratory diseases)
11. Individuals who have cognitive impairments preventing cooperation with device use
12. Individuals who have complaints of device-related side effects or potential rehabilitation discontinuation
13. Patients who are determined to be pregnant or potentially pregnant based on the medical interview
14. Individuals who have any other clinically significant findings deemed inappropriate by the investigator
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yonsei University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Na Young Kim, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Severance Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yongin Severance Hospital

Yongin-si, Gyeonggi-do, South Korea, South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Na Young Kim, MD, PhD

Role: CONTACT

+82 010 9127 4482

Hwi Woo Yang

Role: CONTACT

+82 010 7360 4439

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Na Young Kim

Role: primary

+82 010 9127 4482

Hwi Woo Yang

Role: backup

+82 010 7360 4439

References

Explore related publications, articles, or registry entries linked to this study.

Godi M, Franchignoni F, Caligari M, Giordano A, Turcato AM, Nardone A. Comparison of reliability, validity, and responsiveness of the mini-BESTest and Berg Balance Scale in patients with balance disorders. Phys Ther. 2013 Feb;93(2):158-67. doi: 10.2522/ptj.20120171. Epub 2012 Sep 27.

Reference Type BACKGROUND
PMID: 23023812 (View on PubMed)

Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985 Apr 15;132(8):919-23.

Reference Type BACKGROUND
PMID: 3978515 (View on PubMed)

Hwang R, Morris NR, Mandrusiak A, Mudge A, Suna J, Adsett J, Russell T. Timed Up and Go Test: A Reliable and Valid Test in Patients With Chronic Heart Failure. J Card Fail. 2016 Aug;22(8):646-50. doi: 10.1016/j.cardfail.2015.09.018. Epub 2015 Oct 9.

Reference Type BACKGROUND
PMID: 26456063 (View on PubMed)

Santos M, Zdravevski E, Albuquerque C, Coelho PJ, Pires IM. Ten Meter Walk Test for motor function assessment with technological devices based on lower members' movements: A systematic review. Comput Biol Med. 2025 Mar;187:109734. doi: 10.1016/j.compbiomed.2025.109734. Epub 2025 Feb 3.

Reference Type BACKGROUND
PMID: 39904103 (View on PubMed)

Dolny DG, Collins MG, Wilson T, Germann ML, Davis HP. Validity of lower extremity strength and power utilizing a new closed chain dynamometer. Med Sci Sports Exerc. 2001 Jan;33(1):171-5. doi: 10.1097/00005768-200101000-00026.

Reference Type BACKGROUND
PMID: 11194105 (View on PubMed)

Kim Heon-tae, Moon Jun-bae, Ryu Seung-ho, and Kang Min-soo. Validity study of the Korean version of the International Physical Activity Questionnaire (IPAQ): Verification of construct-related validity. Korean Journal of Physical Education No. 2017;56

Reference Type BACKGROUND

Gajdosik RL, Bohannon RW. Clinical measurement of range of motion. Review of goniometry emphasizing reliability and validity. Phys Ther. 1987 Dec;67(12):1867-72. doi: 10.1093/ptj/67.12.1867.

Reference Type BACKGROUND
PMID: 3685114 (View on PubMed)

Cuthbert SC, Goodheart GJ Jr. On the reliability and validity of manual muscle testing: a literature review. Chiropr Osteopat. 2007 Mar 6;15:4. doi: 10.1186/1746-1340-15-4.

Reference Type BACKGROUND
PMID: 17341308 (View on PubMed)

Mehrholz J, Wagner K, Rutte K, Meissner D, Pohl M. Predictive validity and responsiveness of the functional ambulation category in hemiparetic patients after stroke. Arch Phys Med Rehabil. 2007 Oct;88(10):1314-9. doi: 10.1016/j.apmr.2007.06.764.

Reference Type BACKGROUND
PMID: 17908575 (View on PubMed)

Setoguchi D, Kinoshita K, Kamada S, Sakamoto T, Kise N, Kotani N, Goto K, Shiota E, Inoue T, Yamamoto T. Hybrid Assistive Limb improves restricted hip extension after total hip arthroplasty. Assist Technol. 2022 Jan 2;34(1):112-120. doi: 10.1080/10400435.2020.1712498. Epub 2020 Jan 22.

Reference Type BACKGROUND
PMID: 31909703 (View on PubMed)

Li J, Wu T, Xu Z, Gu X. A pilot study of post-total knee replacement gait rehabilitation using lower limbs robot-assisted training system. Eur J Orthop Surg Traumatol. 2014 Feb;24(2):203-8. doi: 10.1007/s00590-012-1159-9. Epub 2013 Jan 9.

Reference Type BACKGROUND
PMID: 23412304 (View on PubMed)

Rohner E, Mayfarth A, Sternitzke C, Layher F, Scheidig A, Gross HM, Matziolis G, Bohle S, Sander K. Mobile Robot-Based Gait Training after Total Hip Arthroplasty (THA) Improves Walking in Biomechanical Gait Analysis. J Clin Med. 2021 May 29;10(11):2416. doi: 10.3390/jcm10112416.

Reference Type BACKGROUND
PMID: 34072524 (View on PubMed)

Koseki K, Mutsuzaki H, Yoshikawa K, Iwai K, Hashizume Y, Nakazawa R, Kohno Y. Early Recovery of Walking Ability in Patients After Total Knee Arthroplasty Using a Hip-Wearable Exoskeleton Robot: A Case-Controlled Clinical Trial. Geriatr Orthop Surg Rehabil. 2021 Jun 28;12:21514593211027675. doi: 10.1177/21514593211027675. eCollection 2021.

Reference Type BACKGROUND
PMID: 34262793 (View on PubMed)

Kirkley A, Webster-Bogaert S, Litchfield R, Amendola A, MacDonald S, McCalden R, Fowler P. The effect of bracing on varus gonarthrosis. J Bone Joint Surg Am. 1999 Apr;81(4):539-48. doi: 10.2106/00004623-199904000-00012.

Reference Type BACKGROUND
PMID: 10225800 (View on PubMed)

Pham T, Maillefert JF, Hudry C, Kieffert P, Bourgeois P, Lechevalier D, Dougados M. Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis. A two-year prospective randomized controlled study. Osteoarthritis Cartilage. 2004 Jan;12(1):46-55. doi: 10.1016/j.joca.2003.08.011.

Reference Type BACKGROUND
PMID: 14697682 (View on PubMed)

Brouwer RW, Jakma TS, Verhagen AP, Verhaar JA, Bierma-Zeinstra SM. Braces and orthoses for treating osteoarthritis of the knee. Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004020. doi: 10.1002/14651858.CD004020.pub2.

Reference Type BACKGROUND
PMID: 15674927 (View on PubMed)

Van der Esch M, Heijmans M, Dekker J. Factors contributing to possession and use of walking aids among persons with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 2003 Dec 15;49(6):838-42. doi: 10.1002/art.11463.

Reference Type BACKGROUND
PMID: 14673971 (View on PubMed)

Rajaee SS, Campbell JC, Mirocha J, Paiement GD. Increasing Burden of Total Hip Arthroplasty Revisions in Patients Between 45 and 64 Years of Age. J Bone Joint Surg Am. 2018 Mar 21;100(6):449-458. doi: 10.2106/JBJS.17.00470.

Reference Type BACKGROUND
PMID: 29557860 (View on PubMed)

Berliner JL, Brodke DJ, Chan V, SooHoo NF, Bozic KJ. John Charnley Award: Preoperative Patient-reported Outcome Measures Predict Clinically Meaningful Improvement in Function After THA. Clin Orthop Relat Res. 2016 Feb;474(2):321-9. doi: 10.1007/s11999-015-4350-6.

Reference Type BACKGROUND
PMID: 26201420 (View on PubMed)

Hawker GA, Badley EM, Croxford R, Coyte PC, Glazier RH, Guan J, Harvey BJ, Williams JI, Wright JG. A population-based nested case-control study of the costs of hip and knee replacement surgery. Med Care. 2009 Jul;47(7):732-41. doi: 10.1097/MLR.0b013e3181934553.

Reference Type BACKGROUND
PMID: 19536034 (View on PubMed)

Judge A, Arden NK, Batra RN, Thomas G, Beard D, Javaid MK, Cooper C, Murray D; Exeter Primary Outcomes Study (EPOS) group. The association of patient characteristics and surgical variables on symptoms of pain and function over 5 years following primary hip-replacement surgery: a prospective cohort study. BMJ Open. 2013 Mar 1;3(3):e002453. doi: 10.1136/bmjopen-2012-002453.

Reference Type BACKGROUND
PMID: 23457332 (View on PubMed)

Kinds MB, Welsing PM, Vignon EP, Bijlsma JW, Viergever MA, Marijnissen AC, Lafeber FP. A systematic review of the association between radiographic and clinical osteoarthritis of hip and knee. Osteoarthritis Cartilage. 2011 Jul;19(7):768-78. doi: 10.1016/j.joca.2011.01.015. Epub 2011 Jan 31.

Reference Type BACKGROUND
PMID: 21281726 (View on PubMed)

Murphy NJ, Eyles JP, Hunter DJ. Hip Osteoarthritis: Etiopathogenesis and Implications for Management. Adv Ther. 2016 Nov;33(11):1921-1946. doi: 10.1007/s12325-016-0409-3. Epub 2016 Sep 26.

Reference Type BACKGROUND
PMID: 27671326 (View on PubMed)

Alves EM, Angrisani AT, Santiago MB. The use of extracorporeal shock waves in the treatment of osteonecrosis of the femoral head: a systematic review. Clin Rheumatol. 2009 Nov;28(11):1247-51. doi: 10.1007/s10067-009-1231-y. Epub 2009 Jul 17.

Reference Type BACKGROUND
PMID: 19609482 (View on PubMed)

Bennell KL, Buchbinder R, Hinman RS. Physical therapies in the management of osteoarthritis: current state of the evidence. Curr Opin Rheumatol. 2015 May;27(3):304-11. doi: 10.1097/BOR.0000000000000160.

Reference Type BACKGROUND
PMID: 25775185 (View on PubMed)

Gay C, Chabaud A, Guilley E, Coudeyre E. Educating patients about the benefits of physical activity and exercise for their hip and knee osteoarthritis. Systematic literature review. Ann Phys Rehabil Med. 2016 Jun;59(3):174-183. doi: 10.1016/j.rehab.2016.02.005. Epub 2016 Apr 1.

Reference Type BACKGROUND
PMID: 27053003 (View on PubMed)

Paans N, van den Akker-Scheek I, Dilling RG, Bos M, van der Meer K, Bulstra SK, Stevens M. Effect of exercise and weight loss in people who have hip osteoarthritis and are overweight or obese: a prospective cohort study. Phys Ther. 2013 Feb;93(2):137-46. doi: 10.2522/ptj.20110418. Epub 2012 Sep 27.

Reference Type BACKGROUND
PMID: 23023813 (View on PubMed)

Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J Orthop. 2015 Sep 18;6(8):590-601. doi: 10.5312/wjo.v6.i8.590. eCollection 2015 Sep 18.

Reference Type BACKGROUND
PMID: 26396935 (View on PubMed)

Joo YB, Sung YK, Shim JS, Kim JH, Lee EK, Lee HS, Bae SC. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study. Rheumatol Int. 2015 May;35(5):879-86. doi: 10.1007/s00296-014-3147-3. Epub 2014 Oct 10.

Reference Type BACKGROUND
PMID: 25300729 (View on PubMed)

Culliford DJ, Maskell J, Kiran A, Judge A, Javaid MK, Cooper C, Arden NK. The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database. Osteoarthritis Cartilage. 2012 Jun;20(6):519-24. doi: 10.1016/j.joca.2012.02.636. Epub 2012 Mar 3.

Reference Type BACKGROUND
PMID: 22395038 (View on PubMed)

Murphy LB, Helmick CG, Schwartz TA, Renner JB, Tudor G, Koch GG, Dragomir AD, Kalsbeek WD, Luta G, Jordan JM. One in four people may develop symptomatic hip osteoarthritis in his or her lifetime. Osteoarthritis Cartilage. 2010 Nov;18(11):1372-9. doi: 10.1016/j.joca.2010.08.005. Epub 2010 Aug 14.

Reference Type BACKGROUND
PMID: 20713163 (View on PubMed)

Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008 Jan;58(1):15-25. doi: 10.1002/art.23177.

Reference Type BACKGROUND
PMID: 18163481 (View on PubMed)

Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014 Jul;73(7):1323-30. doi: 10.1136/annrheumdis-2013-204763. Epub 2014 Feb 19.

Reference Type BACKGROUND
PMID: 24553908 (View on PubMed)

Alexander NB. Gait disorders in older adults. J Am Geriatr Soc. 1996 Apr;44(4):434-51. doi: 10.1111/j.1532-5415.1996.tb06417.x. No abstract available.

Reference Type BACKGROUND
PMID: 8636592 (View on PubMed)

Baker JM. Gait Disorders. Am J Med. 2018 Jun;131(6):602-607. doi: 10.1016/j.amjmed.2017.11.051. Epub 2017 Dec 27.

Reference Type BACKGROUND
PMID: 29288631 (View on PubMed)

Mirelman A, Shema S, Maidan I, Hausdorff JM. Gait. Handb Clin Neurol. 2018;159:119-134. doi: 10.1016/B978-0-444-63916-5.00007-0.

Reference Type BACKGROUND
PMID: 30482309 (View on PubMed)

Kang Y, NA D-L, Hahn S. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. Journal of the Korean neurological association 1997:300-308

Reference Type BACKGROUND

Lee, Sang-Heon, Bong-Keun Jung, and So-Yeon Park. "Korean Translation and Psychometric Properties of Quebec User Evaluation of Satisfaction Assistive Technology 2.0." Journal of the Korea Academia-Industrial Cooperation Society. The Korea Academia-Industrial Cooperation Society, July 31, 2013.

Reference Type BACKGROUND

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9-2025-0018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.